The abstract is read at the publisher; the summary is JClub's.
Global fungal skin disease DALYs rose from 1.5 million (95% UI, 0.6–3.2 million) in 1990 to 2.0 million (95% UI, 0.8–4.2 million) in 2023, and are projected to reach ~2.6 million by 2050.
- Why it matters: The burden is frequently overlooked despite being common and nonfatal, and drivers like obesity, diabetes, climate-related environmental change, and antifungal-resistant dermatophytes may increase future impact.
- What they did: Using Global Burden of Disease 2023 estimates across 21 regions, the study quantified DALYs and age-standardized DALY rates with joinpoint regression, decomposition, and Bayesian age-period-cohort projections for 2024–2050.
- The result: Age-standardized DALY rates are projected to increase from 26 (95% UI, 10–54) in 2023 to 29 (95% UI, 16–53) per 100,000 by 2050, with South Asia projected to account for 45.2% (95% UI, -10.7 to 155.0) of future global DALY increases.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.